PPARG and myocardial infarction: Shinmura et al. reported the pioglitazone induces the cardiomyogenic trans-differentiation of BM-MSCs via PPAR-γ activation and that the transplantation of pioglitazone pretreated MSCs improves cardiac function in a myocardial infarction animal model [12].